Trimethoprim–Sulfamethoxazole–Induced Thrombotic Thrombocytopenic Purpura

Authors

• Renee Morecroft, HCA HealthcareFollow
• Jyoti Moorjani, HCA HealthcareFollow
• Mohamed Hussam Hallak, HCA HealthcareFollow
• Tathana Rivera Hernandez, HCA HealthcareFollow
• Isabella Estrada, HCA HealthcareFollow
• Hammad Awad, HCA HealthcareFollow
• Payam Nabizadeh-Eraghi, HCA HealthcareFollow

Files

Division

South Atlantic

Hospital

HCA Florida Orange Park Hospital

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2026

Keywords

immune-mediated thrombotic thrombocytopenic purpura, drug-related side effects and adverse reactions, antibiotics

Disciplines

Critical Care | Hemic and Lymphatic Diseases | Internal Medicine | Medicine and Health Sciences

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Morecroft, Renee; Moorjani, Jyoti; Hallak, Mohamed Hussam; Rivera Hernandez, Tathana; Estrada, Isabella; Awad, Hammad; and Nabizadeh-Eraghi, Payam, "Trimethoprim–Sulfamethoxazole–Induced Thrombotic Thrombocytopenic Purpura" (2026). South Atlantic Division GME Research Days 2026. 35.
https://scholarlycommons.hcahealthcare.com/southatlantic2026/35